Cite
Adherence with intravenous zoledronate and intravenous ibandronate in the United States Medicare population.
MLA
Curtis, Jeffrey R., et al. “Adherence with Intravenous Zoledronate and Intravenous Ibandronate in the United States Medicare Population.” Arthritis Care & Research, vol. 64, no. 7, July 2012, pp. 1054–60. EBSCOhost, https://doi.org/10.1002/acr.21638.
APA
Curtis, J. R., Yun, H., Matthews, R., Saag, K. G., & Delzell, E. (2012). Adherence with intravenous zoledronate and intravenous ibandronate in the United States Medicare population. Arthritis Care & Research, 64(7), 1054–1060. https://doi.org/10.1002/acr.21638
Chicago
Curtis, Jeffrey R, Huifeng Yun, Robert Matthews, Kenneth G Saag, and Elizabeth Delzell. 2012. “Adherence with Intravenous Zoledronate and Intravenous Ibandronate in the United States Medicare Population.” Arthritis Care & Research 64 (7): 1054–60. doi:10.1002/acr.21638.